SCHEMBL6139961

SCHEMBL6139961

O=C(O)[C@H](Cc1ccc2nc(-c3c(Cl)cccc3Cl)ccc2c1)NC(=O)N1C(=O)CC[C@H]1Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 12/20 0.60
ITGAV P06756 1/20 0.60
ITGA4 P13612 11/20 0.41
ITGB7 P26010 5/20 0.41
POLB P06746 1/20 0.39
ABL1 P00519 1/20 0.38
SCN3A Q9NY46 1/20 0.37
FPR2 P25090 1/20 0.36
PIN1 Q13526 2/20 0.35
TACR1 P25103 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3318084 0.82 ITGB1 (0.61) ITGB1ITGAVITGA4ITGB7ALDH1A1
SCHEMBL3317244 0.78 ITGB1 (0.70) ITGB1ITGAVITGA4ITGB7POLB
SCHEMBL4419511 0.77 ITGB1 (0.83) ITGB1ITGAVITGA4ITGB7SCN3A
SCHEMBL6140062 0.76 ITGB1 (0.59) ITGB1ITGAVITGA4ITGB7ABL1
SCHEMBL8352229 0.76 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7
SCHEMBL3313356 0.76 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7
SCHEMBL3313373 0.76 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7
SCHEMBL3316398 0.76 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7
SCHEMBL3312947 0.75 ITGB1 (0.67) ITGB1ITGAVITGA4ITGB7ABL1
SCHEMBL3318272 0.74 ITGB1 (0.85) ITGB1ITGAVITGA4ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2005-02-02 EP disclosed
WO-2003093237-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2003-11-13 WO disclosed